Deflazacort in pharma franchise in Rourkela

Deflazacort in PCD pharma franchise in Dehradun

Deflazacort in top pharma company in Kolhapur

Deflazacort in pcd pharma supplier in Meghalaya

Deflazacort in phama franchise company in India
Deflazacort in phama distributor in Meerut

Home/Products /deflazacort-18mg-tablet

Defziff 18 Tablet

Composition : Deflazacort (18mg) Tablet

Dosage Form : Tablet

Packaging Type : Alu Alu

Packaging : 10*10

Price : ₹192/-

Defziff 18 Tablet is a prescription medication that contains deflazacort, a synthetic corticosteroid known for its anti-inflammatory and immunosuppressive properties. It is primarily used in the management of various autoimmune disorders and inflammatory conditions, offering relief from symptoms associated with these diseases. Defziff 18 is particularly effective in treating conditions such as rheumatoid arthritis, systemic lupus erythematosus, and certain forms of vasculitis. It may also be indicated for specific skin disorders and certain allergic reactions, enhancing the quality of life for patients by reducing pain and swelling.

Deflazacort works by suppressing the immune response, thereby minimizing inflammation and providing symptomatic relief. This action helps manage flare-ups and reduces the severity of symptoms, allowing patients to engage more actively in daily activities. The tablet form makes it easy to administer, ensuring consistent therapeutic effects when taken as prescribed.

Read More

About the Product

Defziff 18 Tablet is a prescription medication that contains deflazacort, a synthetic corticosteroid known for its anti-inflammatory and immunosuppressive properties. It is primarily used in the management of various autoimmune disorders and inflammatory conditions, offering relief from symptoms associated with these diseases. Defziff 18 is particularly effective in treating conditions such as rheumatoid arthritis, systemic lupus erythematosus, and certain forms of vasculitis. It may also be indicated for specific skin disorders and certain allergic reactions, enhancing the quality of life for patients by reducing pain and swelling.

Deflazacort works by suppressing the immune response, thereby minimizing inflammation and providing symptomatic relief. This action helps manage flare-ups and reduces the severity of symptoms, allowing patients to engage more actively in daily activities. The tablet form makes it easy to administer, ensuring consistent therapeutic effects when taken as prescribed.

Common side effects may include weight gain, increased appetite, mood changes, and gastrointestinal disturbances. More serious effects can occur; consult a healthcare provider for detailed information.

Defziff 18 Tablet is indicated for the treatment of autoimmune diseases, inflammatory conditions, and certain allergic reactions.

Always follow your healthcare provider’s instructions regarding dosage and duration of treatment. Do not discontinue use abruptly without consulting a physician, as this may lead to withdrawal symptoms. In summary, Defziff 18 Tablet offers a valuable treatment option for managing a range of inflammatory and autoimmune conditions. Its effectiveness, combined with careful adherence to dosing guidelines, can help patients achieve better health outcomes while minimizing the risk of potential side effects. Always discuss any concerns or questions with a healthcare professional to ensure safe and effective use of this medication.

Store at room temperature, away from moisture and direct sunlight. Keep out of reach of children.

Get in Touch

Regulatory Compliance & Professional Verification

This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.

  • No Consumer Sale: We do not entertain retail inquiries or direct sales to patients.
  • Information Accuracy: While we strive for accuracy, product availability, packaging, and regulatory status may change based on CDSCO guidelines and state-specific drug laws.
  • Medical Advice: Patients are strictly advised not to self-medicate or use this information for treatment. Always consult a qualified medical practitioner.
  • Licensing: All business associations are subject to the submission of valid GST and Drug License (DL) documentation.

Strategic Advisory

Ms. Shiwani Dhiman

VP-Strategic Outreach & Engagement

Ms. Shiwani specializes in market outreach and strategic partnership orchestration for entrepreneurs building scalable PCD Pharma Franchise models.

View Professional Profile

Start Your Journey

Partner With Cafoli

Ready to Dominate your territory with a Monopoly-Based PCD Franchise? Join our rapidly growing network of successful franchise partners and turn your ambitions into reality. Limited Territories Available — Don’t Miss Out!

Quick Navigation